China will provide 10 million doses of Sinovac vaccine to South Africa

On the evening of July 25th, South African President Cyril Ramaphosa delivered a speech on the development of the third wave of the new crown epidemic. As the number of infections in Gauteng has fallen, Western Cape, Eastern Cape and The daily number of new infections in KwaZulu Natal province continues to rise.

After a period of relative stability, the number of infections in the Northern Cape has also seen a worrying rise. In all these cases, the infection is caused by the Delta variant virus. As we said before, it spreads more easily than the previous variant virus.

The President believes that we must contain the spread of the new coronavirus and limit its impact on economic activities. We must speed up our vaccination program so that the vast majority of adult South Africans can be vaccinated before the end of the year.

The Numolux Group, a Centurion-headquartered company of Coxing in South Africa, said that this proposal is attributed to the good relationship established between South Africa and China through the BRICS and China-Africa Cooperation Forum.

After a study in The Lancet found that the human body after being vaccinated with BioNTech vaccines (such as Pfizer vaccine) can produce more than ten times the antibodies, Numolux Group assured the public that the Sinovac vaccine is also effective against the Delta variant of the new crown virus.

Numolux Group stated that first, the applicant Curanto Pharma must submit the final results of the Sinovac vaccine clinical study. If approved, 2.5 million doses of Sinovac vaccine will be available immediately.

Numolux Group stated, “Sinovac is responding to urgent orders from more than 50 countries/regions every day. However, they stated that for South Africa, they will immediately produce 2.5 million doses of vaccine and another 7.5 million doses at the time of order.”

In addition, the vaccine has a shelf life of 24 months and can be stored in an ordinary refrigerator.